Clinical Trial Update: Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two inhaled doses of TPI ASM8 to placebo in mild-to-moderate asthma was terminated. The update notes safety and efficacy data from the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• TPI ASM8

Snippet

Sponsor: Syntara | Conditions: Asthma | Phase 2 | Status: TERMINATED